SCHEMBL1655329

SCHEMBL1655329

C=C(C)[C@H]1CC[C@H](C)[C@@H](O)C1

nearest known ligand 0.42

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA4 P22748 1/20 0.42
▸ TP53 P04637 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ JAK3 P52333 3/20 0.33
▸ LMNA P02545 1/20 0.31
▸ TRPA1 O75762 2/20 0.30
▸ TRPM8 Q7Z2W7 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18470003 1.00 CA1 (0.42) CA1CA2CA4TP53TSHR
SCHEMBL15013813 1.00 CA1 (0.42) CA1CA2CA4TP53TSHR
SCHEMBL295511 1.00 CA1 (0.42) CA1CA2CA4TP53TSHR
SCHEMBL15012789 1.00 CA1 (0.42) CA1CA2CA4TP53TSHR
SCHEMBL23988644 1.00 CA1 (0.42) CA1CA2CA4TP53TSHR
SCHEMBL23988604 1.00 CA1 (0.42) CA1CA2CA4TP53TSHR
SCHEMBL1655773 1.00 CA1 (0.42) CA1CA2CA4TP53TSHR
SCHEMBL10265013 1.00 CA1 (0.42) CA1CA2CA4TP53TSHR
SCHEMBL20609240 1.00 CA1 (0.42) CA1CA2CA4TP53TSHR
SCHEMBL15012431 1.00 CA1 (0.42) CA1CA2CA4TP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4096618-B1 A MIXTURE COMPRISING 1,2-ALKANEDIOLS SYMRISE AG (DE) 2025-01-29 — — EP claimed
EP-4438065-A2 A MIXTURE COMPRISING 1,2-ALKANEDIOLS Symrise AG (DE) 2024-10-02 — — EP claimed
EP-4096618-A1 A MIXTURE COMPRISING 1,2-ALKANEDIOLS Symrise AG (DE) 2022-12-07 — — EP claimed
WO-2022217147-A1 METHODS FOR IMPROVING CUTANEOUS PERMEATION OF CANNABINOIDS AND FATTY ACID AMIDES ROSENFELD MARK J (US) 2022-10-13 — — WO claimed
WO-2022122143-A1 A MIXTURE COMPRISING 1,2-ALKANEDIOLS SYMRISE AG (DE) 2022-06-16 — — WO claimed
EP-2787825-B2 ANTIMICROBIAL COMPOSITION UNILEVER GLOBAL IP LTD (GB) 2021-11-03 — — EP claimed
US-20190155975-A9 Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions THE PROCTER & GAMBLE COMPANY 2019-05-23 — — US claimed
US-20190010427-A1 SILICONE COMPOUNDS THE PROCTER & GAMBLE COMPANY 2019-01-10 — — US claimed
US-20190010293-A1 SILICONE COMPOUNDS THE PROCTER & GAMBLE COMPANY 2019-01-10 — — US claimed
US-10113140-B2 Freshening compositions and devices comprising same THE PROCTER & GAMBLE COMPANY (US) 2018-10-30 — — US claimed
US-20160090555-A1 CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2016-03-31 — — US claimed
US-20160089317-A1 ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2016-03-31 — — US claimed
WO-2016049458-A1 DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 — — WO claimed
US-20160089318-A1 PERSONAL CARE COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2016-03-31 — — US claimed
US-20160089465-A1 FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME THE PROCTER & GAMBLE COMPANY 2016-03-31 — — US claimed
US-20160089462-A1 FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME THE PROCTER & GAMBLE COMPANY 2016-03-31 — — US claimed
US-20140350122-A1 ANTIMICROBIAL COMPOSITION ROHM AND HAAS COMPANY (US) 2014-11-27 — — US claimed
EP-2787825-A1 ANTIMICROBIAL COMPOSITION Unilever N.V. (NL) 2014-10-15 — — EP claimed
WO-2013083595-A1 ANTIMICROBIAL COMPOSITION UNILEVER N.V. (NL) 2013-06-13 — — WO claimed
CN-102946876-A Viral inhibitor compositions for in vivo therapeutic use comprising combination of (-) -carvone, geraniol and further essential oil component CESA ALLIANCE SA 2013-02-27 — — CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160089317-A1 ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS LPO, QDPR, TYR CA1 4111/4885CA2 3228/4885CA4 670/4885
US-20140350122-A1 ANTIMICROBIAL COMPOSITION TMSB10, TAS2R40, TAS2R50 CA1 4839/4885CA2 4596/4885CA4 4823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback